Abstract
Expression of Concern to: Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have